Acasti Common Stock Shares Outstanding from 2010 to 2024
| ACST Stock | USD 3.19 0.22 7.41% |
Common Stock Shares Outstanding | First Reported 2008-09-30 | Previous Quarter 7.6 M | Current Value 11.5 M | Quarterly Volatility 4.2 M |
Check Acasti Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Acasti Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 106 K, Interest Expense of 81.7 M or Other Operating Expenses of 12.8 M, as well as many indicators such as Price To Sales Ratio of 360, Dividend Yield of 0.0 or PTB Ratio of 0.26. Acasti financial statements analysis is a perfect complement when working with Acasti Pharma Valuation or Volatility modules.
Acasti | Common Stock Shares Outstanding |
Latest Acasti Pharma's Common Stock Shares Outstanding Growth Pattern
Below is the plot of the Common Stock Shares Outstanding of Acasti Pharma over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Acasti Pharma's Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Acasti Pharma's overall financial position and show how it may be relating to other accounts over time.
| Common Stock Shares Outstanding | 10 Years Trend |
|
Common Stock Shares Outstanding |
| Timeline |
Acasti Common Stock Shares Outstanding Regression Statistics
| Arithmetic Mean | 3,163,467 | |
| Geometric Mean | 1,098,351 | |
| Coefficient Of Variation | 107.40 | |
| Mean Deviation | 2,943,179 | |
| Median | 2,185,814 | |
| Standard Deviation | 3,397,466 | |
| Sample Variance | 11.5T | |
| Range | 8.9M | |
| R-Value | 0.88 | |
| Mean Square Error | 2.8T | |
| R-Squared | 0.78 | |
| Significance | 0.000013 | |
| Slope | 670,379 | |
| Total Sum of Squares | 161.6T |
Acasti Common Stock Shares Outstanding History
About Acasti Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Acasti Pharma income statement, its balance sheet, and the statement of cash flows. Acasti Pharma investors use historical funamental indicators, such as Acasti Pharma's Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Although Acasti Pharma investors may use each financial statement separately, they are all related. The changes in Acasti Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Acasti Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Acasti Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Acasti Pharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.6 M | 9 M |
Pair Trading with Acasti Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Acasti Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acasti Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Acasti Stock
Moving against Acasti Stock
| 0.82 | ELDN | Eledon Pharmaceuticals | PairCorr |
| 0.81 | OGN | Organon | PairCorr |
| 0.8 | VRCA | Verrica Pharmaceuticals | PairCorr |
| 0.55 | MCRB | Seres Therapeutics | PairCorr |
| 0.54 | HOOK | Hookipa Pharma | PairCorr |
The ability to find closely correlated positions to Acasti Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Acasti Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Acasti Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Acasti Pharma to buy it.
The correlation of Acasti Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Acasti Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Acasti Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Acasti Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Acasti Stock Analysis
When running Acasti Pharma's price analysis, check to measure Acasti Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acasti Pharma is operating at the current time. Most of Acasti Pharma's value examination focuses on studying past and present price action to predict the probability of Acasti Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acasti Pharma's price. Additionally, you may evaluate how the addition of Acasti Pharma to your portfolios can decrease your overall portfolio volatility.